Therapeutic workshops: Polypharmacy and deprescribing

These Face 2 Face or virtual workshops provide an opportunity for medicines optimisation team members and / or practice-based pharmacists and technicians, GPs and nurse prescribers to:

  • update clinical knowledge
  • be aware of the latest national guidance
  • network with colleagues
  • consider local implementation to support best practice and patient care

The workshops include a mix of lecture-style presentations and case studies plus plenty of opportunities for interaction. It also supports your professional revalidation.

Workshop content:

  • Polypharmacy and deprescribing – the theory
    – Definitions and evidence base
    – International and national resources
    – Frailty, multimorbidity and end of life
  • Polypharmacy and deprescribing – practical issues
    – Agreeing treatment goals
    – Shared decision making and patient decision aids
    – Medication review and tools to help
  • Anticholinergic burden
    – Evidence base for cognitive impairment
    – ACB scales
    – NICE guideline 67 – use of anticholinergics in people with dementia
  • Medicines Optimisation Polypharmacy Prescribing Comparators

If you’re interested in attending or hosting a workshop, please contact elearning@prescqipp.info.

SKU: pandd_workshop Category:

Description

These Face 2 Face or virtual workshops provide an opportunity for medicines optimisation team members and / or practice-based pharmacists and technicians, GPs and nurse prescribers to:

  • update clinical knowledge
  • be aware of the latest national guidance
  • network with colleagues
  • consider local implementation to support best practice and patient care

The workshops include a mix of lecture-style presentations and case studies plus plenty of opportunities for interaction. It also supports your professional revalidation.

Workshop content:

  • Polypharmacy and deprescribing – the theory
    – Definitions and evidence base
    – International and national resources
    – Frailty, multimorbidity and end of life
  • Polypharmacy and deprescribing – practical issues
    – Agreeing treatment goals
    – Shared decision making and patient decision aids
    – Medication review and tools to help
  • Anticholinergic burden
    – Evidence base for cognitive impairment
    – ACB scales
    – NICE guideline 67 – use of anticholinergics in people with dementia
  • Medicines Optimisation Polypharmacy Prescribing Comparators

If you’re interested in attending or hosting a workshop, please contact elearning@prescqipp.info.